FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979183913> ?p ?o ?g. }

• W2979183913 endingPage "111747" @default.
• W2979183913 startingPage "111747" @default.
• W2979183913 abstract "The present study reports on evaluation of anti-HCV activity and QSAR of certain arylidenethiazolidinone derivatives as potential inhibitors of HCV-NS5B polymerase. The pursued compounds involving, 5-aryliden-3-arylacetamidothiazolidin-2,4-diones 4-6(a-f), 5-arylidine-2-(N-arylacetamido)-iminothiazolidin-4-one (10) and their rigid counterparts 5-arylidinethiazolotriazines 13-15(a-f), were synthesized and their structures confirmed by spectral and elemental analyses. The results of NS5B polymerase inhibition assay revealed compound 4e, as the most active inhibitor (IC50 = 0.035 μM), which is four folds greater than that of the reference agent, VCH-759, (IC50 = 0.14 μM). Meanwhile, compounds 4b, 4c, 5a, and 5c, and 13b, 14e and 15c displayed equipotency to 2 folds higher activity than VCH-759 (IC50 values: 0.085, 0.14, 0.14, 0.10, 0.12, 0.09 and 0.07 μM, respectively). Assessment of the anti-HCV activity (GT1a) using human hepatoma cell line (Huh-7.5) illustrates superior activity of 4e (EC50 = 3.80 μM) relative to VCH-759 (EC50 = 5.29 μM). Cytotoxicity evaluation on, Transformed normal cell lines (Human Liver Epithelial-2, THLE-2 and Proximal Tubular Epithelial, RPTEC/TERT1), demonstrate enhanced safety profile of 4e (CC50 = 102.77, 161.37 μM, respectively) compared to VCH-759 (CC50 = 61.83, 81.28 μM, respectively). Molecular docking of the synthesized derivatives to NS5B polymerase allosteric site (PDB: 2HWH) showed similar binding modes to that of the co-crystallized ligand. Moreover, QSAR models were established for the studied thiazolidinones and thiazolotriazines to investigate the molecular characteristics contributing to the observed NS5B polymerase inhibition activity. The obtained results inspire further investigations of thiazolidinones and thiazolotriazine aiming at affording more potent, safe and orally active non-nucleoside NS5B polymerase inhibitors as anti-HCV drug candidates." @default.
• W2979183913 created "2019-10-10" @default.
• W2979183913 creator A5003589655 @default.
• W2979183913 creator A5036413661 @default.
• W2979183913 creator A5048610937 @default.
• W2979183913 creator A5051129755 @default.
• W2979183913 date "2019-12-01" @default.
• W2979183913 modified "2023-10-17" @default.
• W2979183913 title "Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors" @default.
• W2979183913 cites W1531200550 @default.
• W2979183913 cites W1825284425 @default.
• W2979183913 cites W1932632320 @default.
• W2979183913 cites W1965962980 @default.
• W2979183913 cites W1973214691 @default.
• W2979183913 cites W1974922859 @default.
• W2979183913 cites W1983534767 @default.
• W2979183913 cites W1988101502 @default.
• W2979183913 cites W1992987492 @default.
• W2979183913 cites W2016412644 @default.
• W2979183913 cites W2019733693 @default.
• W2979183913 cites W2027166401 @default.
• W2979183913 cites W2040245009 @default.
• W2979183913 cites W2045378360 @default.
• W2979183913 cites W2047909810 @default.
• W2979183913 cites W2051855018 @default.
• W2979183913 cites W2052891613 @default.
• W2979183913 cites W2064593501 @default.
• W2979183913 cites W2064733204 @default.
• W2979183913 cites W2066385513 @default.
• W2979183913 cites W2068857175 @default.
• W2979183913 cites W2071873660 @default.
• W2979183913 cites W2082459628 @default.
• W2979183913 cites W2083227934 @default.
• W2979183913 cites W2087843900 @default.
• W2979183913 cites W2090056396 @default.
• W2979183913 cites W2095383111 @default.
• W2979183913 cites W2102030104 @default.
• W2979183913 cites W2108571089 @default.
• W2979183913 cites W2127136473 @default.
• W2979183913 cites W2135763552 @default.
• W2979183913 cites W2143386449 @default.
• W2979183913 cites W2150368001 @default.
• W2979183913 cites W2168432020 @default.
• W2979183913 cites W2171709821 @default.
• W2979183913 cites W2176712993 @default.
• W2979183913 cites W2300316330 @default.
• W2979183913 cites W2319911380 @default.
• W2979183913 cites W2604219750 @default.
• W2979183913 cites W2623221347 @default.
• W2979183913 cites W2673162703 @default.
• W2979183913 cites W2766934373 @default.
• W2979183913 cites W2898026627 @default.
• W2979183913 cites W2899548289 @default.
• W2979183913 cites W2949933758 @default.
• W2979183913 cites W2950247193 @default.
• W2979183913 cites W2951472323 @default.
• W2979183913 cites W2952113856 @default.
• W2979183913 cites W4254987783 @default.
• W2979183913 doi "https://doi.org/10.1016/j.ejmech.2019.111747" @default.
• W2979183913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31604164" @default.
• W2979183913 hasPublicationYear "2019" @default.
• W2979183913 type Work @default.
• W2979183913 sameAs 2979183913 @default.
• W2979183913 citedByCount "21" @default.
• W2979183913 countsByYear W29791839132019 @default.
• W2979183913 countsByYear W29791839132020 @default.
• W2979183913 countsByYear W29791839132021 @default.
• W2979183913 countsByYear W29791839132022 @default.
• W2979183913 countsByYear W29791839132023 @default.
• W2979183913 crossrefType "journal-article" @default.
• W2979183913 hasAuthorship W2979183913A5003589655 @default.
• W2979183913 hasAuthorship W2979183913A5036413661 @default.
• W2979183913 hasAuthorship W2979183913A5048610937 @default.
• W2979183913 hasAuthorship W2979183913A5051129755 @default.
• W2979183913 hasConcept C104317684 @default.
• W2979183913 hasConcept C109316439 @default.
• W2979183913 hasConcept C135763542 @default.
• W2979183913 hasConcept C159047783 @default.
• W2979183913 hasConcept C159110408 @default.
• W2979183913 hasConcept C164126121 @default.
• W2979183913 hasConcept C166342909 @default.
• W2979183913 hasConcept C181199279 @default.
• W2979183913 hasConcept C185592680 @default.
• W2979183913 hasConcept C202751555 @default.
• W2979183913 hasConcept C2522874641 @default.
• W2979183913 hasConcept C2776408679 @default.
• W2979183913 hasConcept C2777752497 @default.
• W2979183913 hasConcept C2781426373 @default.
• W2979183913 hasConcept C2781463415 @default.
• W2979183913 hasConcept C41685203 @default.
• W2979183913 hasConcept C55493867 @default.
• W2979183913 hasConcept C65556437 @default.
• W2979183913 hasConcept C71240020 @default.
• W2979183913 hasConcept C71924100 @default.
• W2979183913 hasConcept C82381507 @default.
• W2979183913 hasConcept C86803240 @default.
• W2979183913 hasConceptScore W2979183913C104317684 @default.
• W2979183913 hasConceptScore W2979183913C109316439 @default.

• next